Sandoz International

Activities: Pharmaceutical

Trending Articles

  1. Agilent boosts contract manufacturing capabilities with acquisition of BIOVECTRA The CDMO acquisition will bolster Agilent's end-to-end production capabilities in a number of popular therapeutics, including GLP-1 medications and ADCs
  2. KBI Biopharma extends contract with a big pharma giant after a successful FDA inspection The contract has been renewed and extended until at least 2029, and will now include the purchase of two therapeutic products
  3. Currax to build novel anti-obesity treatment production facility amidst GLP-1 supply issues The manufacturing facility will be dedicated to the production of anti-obesity drug Contrave, and will double its output in the EU and EEA
  4. New FAIRY viral assay could 'revolutionise' the response to future pandemics The assay, which can detect the infectiousness of a virus in a matter of minutes, offers a quicker and cheaper alternative to the standard cell culture approach
  5. New advice from BOLA and Labtex on cleaning and handling of PTFE products after use The companies share: "Abrasive scouring agents may result in a milkiness of the vessels made of PFA and FEP. You may use all neutral detergents (pH 7). For higher contamination...

Upcoming event

ISPE Singapore

28-30 August 2024 | Conference and exhibition | Singapore See all

Related Content

Sustainability

Sandoz and Teva achieve independent certification for steps to minimise antimicrobial resistance risk

Certification demonstrates their commitment to protecting people and the planet
Manufacturing

Sandoz opens new packaging centre in Stryków, Poland

The generics division of Novartis has invested €42m in the project
Pharmaceutical

Nick Haggar of Sandoz to become new EGA President

Takes up the role on 8 October
Media

Asia and Latin America will drive biosimilars growth in next decade, says Visiongain

Established players will focus on monoclonal antibodies and licensing deals
Ingredients

Sandoz begins clinical trial of biosimilar rituximab

Aims to demonstrate the bioequivalence of the monoclonal antibody
Regulatory

FDA approves first generic version of Lovenox

Sanofi-aventis has reservations about Sandoz drug for treating DVT
Finance

Sandoz to acquire Oriel Therapeutics

Deal will give Sandoz rights to portfolio of respiratory products targeting asthma and COPD
Subscribe now